| mrna metabolic process | GO:0016071 | 84 | 0.568 | |
| rna splicing | GO:0008380 | 54 | 0.517 | |
| male meiosis i | GO:0007141 | 16 | 0.455 | |
| histone modification | GO:0016570 | 159 | 0.291 | |
| chromatin organization | GO:0006325 | 206 | 0.277 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.236 | |
| regulation of cell cycle process | GO:0010564 | 160 | 0.228 | |
| mrna processing | GO:0006397 | 63 | 0.174 | |
| histone lysine methylation | GO:0034968 | 50 | 0.173 | |
| mrna splicing via spliceosome | GO:0000398 | 43 | 0.162 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.162 | |
| protein methylation | GO:0006479 | 81 | 0.155 | |
| regulation of transcription during meiosis | GO:0051037 | 1 | 0.151 | |
| histone methylation | GO:0016571 | 71 | 0.150 | |
| regulation of mrna metabolic process | GO:1903311 | 43 | 0.137 | |
| nuclear division | GO:0000280 | 158 | 0.126 | |
| chromatin modification | GO:0016568 | 187 | 0.121 | |
| rna splicing via transesterification reactions | GO:0000375 | 43 | 0.121 | |
| rna processing | GO:0006396 | 105 | 0.097 | |
| rna splicing via transesterification reactions with bulged adenosine as nucleophile | GO:0000377 | 43 | 0.092 | |
| positive regulation of organelle organization | GO:0010638 | 128 | 0.091 | |
| regulation of rna splicing | GO:0043484 | 37 | 0.088 | |
| neuroblast differentiation | GO:0014016 | 2 | 0.071 | |
| alternative mrna splicing via spliceosome | GO:0000380 | 12 | 0.068 | |
| amine metabolic process | GO:0009308 | 45 | 0.066 | |
| regulation of alternative mrna splicing via spliceosome | GO:0000381 | 8 | 0.065 | |
| regulation of mrna processing | GO:0050684 | 41 | 0.062 | |
| spermatogenesis | GO:0007283 | 284 | 0.062 | |
| regulation of cell division | GO:0051302 | 76 | 0.062 | |
| organelle fission | GO:0048285 | 170 | 0.061 | |
| male gamete generation | GO:0048232 | 285 | 0.060 | |
| meiotic nuclear division | GO:0007126 | 115 | 0.059 | |
| rna interference | GO:0016246 | 2 | 0.059 | |
| stem cell fate specification | GO:0048866 | 3 | 0.059 | |
| regulation of cell cycle checkpoint | GO:1901976 | 9 | 0.053 | |
| stem cell differentiation | GO:0048863 | 268 | 0.051 | |
| meiotic cell cycle | GO:0051321 | 122 | 0.048 | |
| covalent chromatin modification | GO:0016569 | 163 | 0.046 | |
| protein acylation | GO:0043543 | 64 | 0.045 | |
| regulation of mrna splicing via spliceosome | GO:0048024 | 32 | 0.044 | |
| dna metabolic process | GO:0006259 | 303 | 0.044 | |
| pole plasm assembly | GO:0007315 | 2 | 0.043 | |
| regulation of histone h3 k4 methylation | GO:0051569 | 12 | 0.043 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.042 | |
| compound eye development | GO:0048749 | 1 | 0.041 | |
| cellular response to dna damage stimulus | GO:0006974 | 207 | 0.041 | |
| dna dependent dna replication maintenance of fidelity | GO:0045005 | 3 | 0.041 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.039 | |
| regulation of histone methylation | GO:0031060 | 30 | 0.039 | |
| meiosis i | GO:0007127 | 60 | 0.039 | |
| histone h4 k12 acetylation | GO:0043983 | 2 | 0.038 | |
| oocyte anterior posterior axis specification | GO:0007314 | 2 | 0.036 | |
| dna repair | GO:0006281 | 107 | 0.036 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.035 | |
| endocytosis | GO:0006897 | 168 | 0.035 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.034 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.033 | |
| regulation of nuclear division | GO:0051783 | 56 | 0.033 | |
| negative regulation of cell cycle | GO:0045786 | 123 | 0.033 | |
| methylation | GO:0032259 | 134 | 0.033 | |
| intracellular mrna localization | GO:0008298 | 4 | 0.033 | |
| male meiosis | GO:0007140 | 37 | 0.033 | |
| regulation of synaptic growth at neuromuscular junction | GO:0008582 | 4 | 0.032 | |
| regulation of system process | GO:0044057 | 200 | 0.032 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.032 | |
| sensory perception | GO:0007600 | 245 | 0.031 | |
| positive regulation of cellular catabolic process | GO:0031331 | 148 | 0.031 | |
| histone h3 k14 acetylation | GO:0044154 | 3 | 0.030 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.030 | |
| oocyte axis specification | GO:0007309 | 2 | 0.030 | |
| stem cell maintenance | GO:0019827 | 130 | 0.030 | |
| habituation | GO:0046959 | 3 | 0.029 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.029 | |
| cell division | GO:0051301 | 120 | 0.028 | |
| regulation of chromosome organization | GO:0033044 | 83 | 0.028 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.027 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.026 | |
| sensory perception of sound | GO:0007605 | 97 | 0.026 | |
| regulation of defense response | GO:0031347 | 233 | 0.026 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.026 | |
| blastocyst development | GO:0001824 | 80 | 0.026 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.026 | |
| peptidyl lysine modification | GO:0018205 | 77 | 0.026 | |
| positive regulation of dna templated transcription elongation | GO:0032786 | 2 | 0.025 | |
| meiotic cell cycle process | GO:1903046 | 77 | 0.025 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.025 | |
| regulation of meiotic cell cycle | GO:0051445 | 34 | 0.025 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.025 | |
| multicellular organism growth | GO:0035264 | 161 | 0.024 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.024 | |
| regionalization | GO:0003002 | 337 | 0.024 | |
| macromolecule methylation | GO:0043414 | 120 | 0.024 | |
| gene silencing | GO:0016458 | 38 | 0.024 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.024 | |
| gonad development | GO:0008406 | 141 | 0.024 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.023 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.023 | |
| germ cell development | GO:0007281 | 185 | 0.023 | |
| purine nucleotide catabolic process | GO:0006195 | 211 | 0.023 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.023 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.023 | |
| cardiac muscle tissue development | GO:0048738 | 130 | 0.023 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.023 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.023 | |
| posttranscriptional gene silencing | GO:0016441 | 10 | 0.022 | |
| establishment or maintenance of microtubule cytoskeleton polarity | GO:0030951 | 1 | 0.022 | |
| nucleosome positioning | GO:0016584 | 4 | 0.022 | |
| oogenesis | GO:0048477 | 56 | 0.022 | |
| protein alkylation | GO:0008213 | 81 | 0.022 | |
| embryonic axis specification | GO:0000578 | 30 | 0.022 | |
| negative regulation of cell cycle process | GO:0010948 | 69 | 0.022 | |
| regulation of mitotic cell cycle phase transition | GO:1901990 | 73 | 0.022 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.022 | |
| mitotic cell cycle | GO:0000278 | 195 | 0.021 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.021 | |
| heart morphogenesis | GO:0003007 | 178 | 0.021 | |
| blastocyst growth | GO:0001832 | 23 | 0.021 | |
| histone h3 k4 methylation | GO:0051568 | 23 | 0.021 | |
| hematopoietic progenitor cell differentiation | GO:0002244 | 143 | 0.021 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.021 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.020 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.020 | |
| chromatin silencing at rdna | GO:0000183 | 3 | 0.020 | |
| chromosome segregation | GO:0007059 | 48 | 0.020 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.020 | |
| regulation of response to dna damage stimulus | GO:2001020 | 34 | 0.020 | |
| histone deubiquitination | GO:0016578 | 2 | 0.020 | |
| cellular macromolecule catabolic process | GO:0044265 | 206 | 0.019 | |
| oocyte construction | GO:0007308 | 2 | 0.019 | |
| cellular response to cytokine stimulus | GO:0071345 | 189 | 0.019 | |
| cell adhesion | GO:0007155 | 329 | 0.019 | |
| immune effector process | GO:0002252 | 321 | 0.019 | |
| regulation of inflammatory response | GO:0050727 | 147 | 0.019 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.019 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.019 | |
| oxidation reduction process | GO:0055114 | 342 | 0.019 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.019 | |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.019 | |
| cation transmembrane transport | GO:0098655 | 266 | 0.018 | |
| regulation of binding | GO:0051098 | 111 | 0.018 | |
| negative regulation of dna dependent dna replication | GO:2000104 | 1 | 0.018 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.018 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.018 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.018 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.018 | |
| regulation of cell cycle phase transition | GO:1901987 | 77 | 0.017 | |
| positive regulation of chromatin modification | GO:1903310 | 28 | 0.017 | |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.017 | |
| regulation of protein kinase activity | GO:0045859 | 232 | 0.017 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.017 | |
| receptor mediated endocytosis | GO:0006898 | 51 | 0.017 | |
| negative regulation of mesenchymal cell proliferation | GO:0072201 | 3 | 0.017 | |
| multi multicellular organism process | GO:0044706 | 109 | 0.017 | |
| regulation of chromatin organization | GO:1902275 | 57 | 0.017 | |
| cell maturation | GO:0048469 | 127 | 0.017 | |
| stem cell development | GO:0048864 | 219 | 0.017 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.017 | |
| regulation of transcription by chromatin organization | GO:0034401 | 0 | 0.017 | |
| muscle tissue development | GO:0060537 | 308 | 0.016 | |
| positive regulation of cell cycle | GO:0045787 | 92 | 0.016 | |
| ear development | GO:0043583 | 200 | 0.016 | |
| positive regulation of chromosome organization | GO:2001252 | 33 | 0.016 | |
| synapse organization | GO:0050808 | 125 | 0.016 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.016 | |
| mitotic cell cycle process | GO:1903047 | 159 | 0.016 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.015 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.015 | |
| gtp catabolic process | GO:0006184 | 143 | 0.015 | |
| positive regulation of hydrolase activity | GO:0051345 | 148 | 0.015 | |
| respiratory system development | GO:0060541 | 190 | 0.015 | |
| positive regulation of transcription elongation from rna polymerase ii promoter | GO:0032968 | 2 | 0.015 | |
| development of primary sexual characteristics | GO:0045137 | 143 | 0.015 | |
| regulation of response to wounding | GO:1903034 | 189 | 0.015 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.015 | |
| cation transport | GO:0006812 | 399 | 0.015 | |
| g1 s transition of mitotic cell cycle | GO:0000082 | 57 | 0.015 | |
| regulation of chromatin silencing | GO:0031935 | 2 | 0.015 | |
| maternal determination of anterior posterior axis embryo | GO:0008358 | 2 | 0.015 | |
| regulation of gtp catabolic process | GO:0033124 | 113 | 0.015 | |
| extracellular structure organization | GO:0043062 | 148 | 0.015 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.015 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.015 | |
| regulation of histone modification | GO:0031056 | 56 | 0.015 | |
| epithelial cell development | GO:0002064 | 159 | 0.015 | |
| posttranscriptional gene silencing by rna | GO:0035194 | 10 | 0.014 | |
| negative regulation of phosphorylation | GO:0042326 | 166 | 0.014 | |
| regulation of cell cycle g2 m phase transition | GO:1902749 | 10 | 0.014 | |
| rho protein signal transduction | GO:0007266 | 32 | 0.014 | |
| mrna transcription from rna polymerase ii promoter | GO:0042789 | 4 | 0.014 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.014 | |
| canonical wnt signaling pathway | GO:0060070 | 130 | 0.014 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.014 | |
| protein ubiquitination | GO:0016567 | 171 | 0.014 | |
| digestive system development | GO:0055123 | 200 | 0.014 | |
| peptidyl lysine acetylation | GO:0018394 | 45 | 0.014 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.014 | |
| olfactory learning | GO:0008355 | 2 | 0.014 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.014 | |
| regulation of chromatin modification | GO:1903308 | 57 | 0.014 | |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.014 | |
| cognition | GO:0050890 | 149 | 0.014 | |
| developmental maturation | GO:0021700 | 193 | 0.014 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.013 | |
| regulation of protein complex assembly | GO:0043254 | 83 | 0.013 | |
| protein modification by small protein conjugation or removal | GO:0070647 | 207 | 0.013 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.013 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.013 | |
| camera type eye development | GO:0043010 | 266 | 0.013 | |
| genetic imprinting | GO:0071514 | 27 | 0.013 | |
| genitalia development | GO:0048806 | 37 | 0.013 | |
| cell fate determination involved in pattern specification | GO:0060582 | 1 | 0.013 | |
| sensory system development | GO:0048880 | 3 | 0.013 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.013 | |
| cardiac chamber development | GO:0003205 | 108 | 0.013 | |
| gene silencing by mirna | GO:0035195 | 10 | 0.012 | |
| small molecule biosynthetic process | GO:0044283 | 132 | 0.012 | |
| negative regulation of dna replication | GO:0008156 | 4 | 0.012 | |
| regulation of nucleotide metabolic process | GO:0006140 | 169 | 0.012 | |
| positive regulation of histone methylation | GO:0031062 | 16 | 0.012 | |
| dna templated transcription elongation | GO:0006354 | 13 | 0.012 | |
| regulation of intracellular transport | GO:0032386 | 159 | 0.012 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.012 | |
| translation | GO:0006412 | 93 | 0.012 | |
| protein maturation | GO:0051604 | 176 | 0.012 | |
| regulation of protein localization | GO:0032880 | 231 | 0.012 | |
| neuroblast fate commitment | GO:0014017 | 1 | 0.012 | |
| positive regulation of histone h3 k9 methylation | GO:0051574 | 4 | 0.012 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.012 | |
| inflammatory response | GO:0006954 | 244 | 0.012 | |
| microtubule cytoskeleton organization | GO:0000226 | 157 | 0.012 | |
| transcription from rna polymerase i promoter | GO:0006360 | 13 | 0.012 | |
| regulation of rna export from nucleus | GO:0046831 | 4 | 0.012 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.012 | |
| locomotory behavior | GO:0007626 | 195 | 0.012 | |
| positive regulation of gtpase activity | GO:0043547 | 85 | 0.012 | |
| negative regulation of cellular amino acid metabolic process | GO:0045763 | 0 | 0.011 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.011 | |
| digestive tract morphogenesis | GO:0048546 | 147 | 0.011 | |
| lung development | GO:0030324 | 164 | 0.011 | |
| skeletal system development | GO:0001501 | 356 | 0.011 | |
| intracellular protein transport | GO:0006886 | 204 | 0.011 | |
| embryonic organ morphogenesis | GO:0048562 | 276 | 0.011 | |
| histone acetylation | GO:0016573 | 41 | 0.011 | |
| cell cycle checkpoint | GO:0000075 | 47 | 0.011 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.011 | |
| regulation of transcription involved in g1 s transition of mitotic cell cycle | GO:0000083 | 3 | 0.011 | |
| positive regulation of mapk cascade | GO:0043410 | 170 | 0.011 | |
| negative regulation of protein modification process | GO:0031400 | 163 | 0.011 | |
| internal peptidyl lysine acetylation | GO:0018393 | 42 | 0.011 | |
| homeostasis of number of cells | GO:0048872 | 210 | 0.011 | |
| regulation of lymphocyte activation | GO:0051249 | 240 | 0.011 | |
| heart trabecula morphogenesis | GO:0061384 | 26 | 0.011 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.011 | |
| gtp metabolic process | GO:0046039 | 144 | 0.011 | |
| nucleocytoplasmic transport | GO:0006913 | 139 | 0.011 | |
| positive regulation of binding | GO:0051099 | 49 | 0.011 | |
| learning or memory | GO:0007611 | 148 | 0.011 | |
| ossification | GO:0001503 | 216 | 0.011 | |
| cardiac chamber morphogenesis | GO:0003206 | 93 | 0.011 | |
| uterus morphogenesis | GO:0061038 | 2 | 0.011 | |
| protein import into nucleus | GO:0006606 | 95 | 0.011 | |
| mrna transcription | GO:0009299 | 4 | 0.011 | |
| immunoglobulin production | GO:0002377 | 73 | 0.011 | |
| central nervous system neuron differentiation | GO:0021953 | 162 | 0.011 | |
| hormone metabolic process | GO:0042445 | 86 | 0.010 | |
| rna catabolic process | GO:0006401 | 29 | 0.010 | |
| transdifferentiation | GO:0060290 | 1 | 0.010 | |
| regulation of protein maturation | GO:1903317 | 96 | 0.010 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.010 | |
| platelet derived growth factor receptor alpha signaling pathway | GO:0035790 | 3 | 0.010 | |
| placenta development | GO:0001890 | 140 | 0.010 | |
| regulation of asymmetric cell division | GO:0009786 | 4 | 0.010 | |
| maintenance of location | GO:0051235 | 89 | 0.010 | |
| mapk cascade | GO:0000165 | 281 | 0.010 | |
| lateral inhibition | GO:0046331 | 1 | 0.010 | |
| histone h3 k9 methylation | GO:0051567 | 17 | 0.010 | |
| inner ear morphogenesis | GO:0042472 | 101 | 0.010 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.010 | |
| negative regulation of platelet derived growth factor receptor alpha signaling pathway | GO:2000584 | 2 | 0.010 | |
| protein localization to organelle | GO:0033365 | 185 | 0.010 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.010 | |
